Organism name | Ophiorrhiza filistipula |
---|---|
Genus | Ophiorrhiza |
Family | Rubiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Ophiorrhiza |
---|---|
Linked NCBI taxonomy ID | 35912 |
Linked level | genus |
Family in NCBI taxonomy | Rubiaceae |
---|---|
ID | 24966 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002145
![]() |
Camptothecin
|
CHEMBL65
CHEMBL276820 CHEMBL71836 |
D002166
|
140 / 99 / 97 | 79 / 11 | No. 3696 | No. 7 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002145 | 1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002145 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002145 | 7 / 37 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002145 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002145 | 4 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00002145 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002145 | 2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002145 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002145 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002145 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00002145 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002145 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002145 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002145 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002145 | 6 / 4 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002145 | 1 / 1 |
P29466 | Caspase-1 | C14 | C00002145 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002145 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002145 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002145 | 2 / 2 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00002145 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002145 | 11 / 10 |
Q9NZJ5 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Pek | C00002145 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00002145 | 3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002145 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002145 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002145 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002145 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002145 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002145 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00002145 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00002145 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002145 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002145 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002145 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002145 | 0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00002145 | 1 / 2 |
Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | C00002145 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002145 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002145 | 1 / 8 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002145 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00002145 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002145 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002145 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002145 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002145 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002145 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002145 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002145 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002145 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002145 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002145 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00002145 | 4 / 4 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002145 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002145 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002145 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002145 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00002145 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002145 | 0 / 0 |
P09651 | Heterogeneous nuclear ribonucleoprotein A1 | Unclassified protein | C00002145 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002145 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002145 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002145 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002145 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002145 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002145 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002145 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002145 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002145 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002145 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002145 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002145 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00002145 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002145 | 0 / 0 |
P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00002145 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002145 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002145 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002145 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002145 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002145 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002145 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002145 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002145 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002145 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002145 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002145 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002145 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002145 | 1 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002145 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002145 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002145 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002145 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002145 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002145 | 2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00002145 | 5 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002145 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002145 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002145 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002145 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002145 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002145 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002145 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002145 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002145 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002145 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002145 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002145 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00002145 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002145 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002145 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002145 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002145 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002145 | 0 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002145 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002145 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002145 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002145 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002145 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002145 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002145 | 0 / 0 |
O14746 | Telomerase reverse transcriptase | Enzyme | C00002145 | 5 / 5 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002145 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00002145 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002145 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002145 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002145 | 1 / 2 |
P30874 | Somatostatin receptor type 2 | Somatostatin receptor | C00002145 | 0 / 0 |
P31391 | Somatostatin receptor type 4 | Somatostatin receptor | C00002145 | 0 / 0 |
P32745 | Somatostatin receptor type 3 | Somatostatin receptor | C00002145 | 0 / 0 |
P35346 | Somatostatin receptor type 5 | Somatostatin receptor | C00002145 | 0 / 0 |
P30872 | Somatostatin receptor type 1 | Somatostatin receptor | C00002145 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002145
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002145
|
375790 | AGRN | agrin |
C00002145
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002145
|
307 | ANXA4, ANX4, PIG28, ZAP36 | annexin A4 |
C00002145
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002145
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002145
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00002145
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00002145
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00002145
|
675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00002145
|
51719 | CAB39, MO25 | calcium binding protein 39 |
C00002145
|
835 | CASP2, CASP-2, ICH1, NEDD-2, NEDD2, PPP1R57 | caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) |
C00002145
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002145
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002145
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002145
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002145
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00002145
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002145
|
891 | CCNB1, CCNB | cyclin B1 |
C00002145
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00002145
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002145
|
634 | CEACAM1, BGP, BGP1, BGPI | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
C00002145
|
10153 | CEBPZ, CBF, CBF2, HSP-CBF, NOC1 | CCAAT/enhancer binding protein (C/EBP), zeta |
C00002145
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00002145
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002145
|
1806 | DPYD, DHP, DHPDHASE, DPD | dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
C00002145
|
9538 | EI24, EPG4, PIG8, TP53I8 | etoposide induced 2.4 |
C00002145
|
2033 | EP300, KAT3B, RSTS2, p300 | E1A binding protein p300 (EC:2.3.1.48) |
C00002145
|
9852 | EPM2AIP1 | EPM2A (laforin) interacting protein 1 |
C00002145
|
2067 | ERCC1, COFS4, RAD10, UV20 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
C00002145
|
2072 | ERCC4, ERCC11, FANCQ, RAD1, XPF | excision repair cross-complementing rodent repair deficiency, complementation group 4 |
C00002145
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002145
|
2232 | FDXR, ADXR | ferredoxin reductase (EC:1.18.1.6) |
C00002145
|
2395 | FXN, CyaY, FA, FARR, FRDA, X25 | frataxin (EC:1.16.3.1) |
C00002145
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00002145
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002145
|
3183 | HNRNPC, C1, C2, HNRNP, HNRPC, SNRPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) |
C00002145
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002145
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00002145
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002145
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002145
|
3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00002145
|
5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00002145
|
4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00002145
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002145
|
4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00002145
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00002145
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002145
|
406929 | MIR138-1, MIRN138-1 | microRNA 138-1 |
C00002145
|
8440 | NCK2, GRB4, NCKbeta | NCK adaptor protein 2 |
C00002145
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002145
|
1263 | PLK3, CNK, FNK, PRK | polo-like kinase 3 (EC:2.7.11.21) |
C00002145
|
84152 | PPP1R1B, DARPP-32, DARPP32 | protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16) |
C00002145
|
9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 |
C00002145
|
5888 | RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA | RAD51 recombinase |
C00002145
|
5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00002145
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002145
|
5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00002145
|
5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) |
C00002145
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002145
|
6382 | SDC1, CD138, SDC, SYND1, syndecan | syndecan 1 |
C00002145
|
6606 | SMN1, BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3, SMA4, SMA@, SMN, SMNT, T-BCD541, TDRD16A | survival of motor neuron 1, telomeric |
C00002145
|
55512 | SMPD3, NSMASE2 | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12) |
C00002145
|
6667 | SP1 | Sp1 transcription factor |
C00002145
|
6670 | SP3, SPR2 | Sp3 transcription factor |
C00002145
|
6890 | TAP1, ABC17, ABCB2, APT1, D6S114E, PSF-1, PSF1, RING4, TAP1*0102N, TAP1N | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
C00002145
|
30851 | TAX1BP3, TIP-1 | Tax1 (human T-cell leukemia virus type I) binding protein 3 |
C00002145
|
55775 | TDP1 | tyrosyl-DNA phosphodiesterase 1 (EC:3.1.4.-) |
C00002145
|
7057 | THBS1, THBS, THBS-1, TSP, TSP-1, TSP1 | thrombospondin 1 |
C00002145
|
8744 | TNFSF9, 4-1BB-L, CD137L | tumor necrosis factor (ligand) superfamily, member 9 |
C00002145
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00002145
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002145
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00002145
|
11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) |
C00002145
|
7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00002145
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002145
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002145
|
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
C00002145
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#609135 | Aplastic anemia |
O14746
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 |
O14746
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#226980 | Epiphyseal dysplasia, multiple, with early-onset diabetes mellitus |
Q9NZJ5
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 |
O14746
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 |
O14746
|
#178500 | Pulmonary fibrosis, idiopathic; ipf |
O14746
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#603903 | Sickle cell anemia |
P68871
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00764 | Cri du chat syndrome |
O14746
(related)
|
H01132 | Aplastic anemia (AA) |
O14746
(related)
|
H01299 | Idiopathic pulmonary fibrosis |
O14746
(related)
|
H00022 | Bladder cancer |
O14746
(marker)
P00533 (related) P04626 (related) P04637 (related) P68871 (marker) |
H00024 | Prostate cancer |
O14746
(marker)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00512 | Permanent neonatal diabetes mellitus (PNDM) |
Q9NZJ5
(related)
|
H00766 | Wolcott-Rallison syndrome |
Q9NZJ5
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003967 | Diarrhea |
C00002145
|
D005621 | Friedreich Ataxia |
C00002145
|
D005910 | Glioma |
C00002145
|
D018316 | Gliosarcoma |
C00002145
|
D006816 | Huntington Disease |
C00002145
|
D007945 | Leukemia, Lymphoid |
C00002145
|
D007968 | Leukoencephalopathy, Progressive Multifocal |
C00002145
|
D009369 | Neoplasms |
C00002145
|
D009374 | Neoplasms, Experimental |
C00002145
|
D009503 | Neutropenia |
C00002145
|
D024801 | Tauopathies |
C00002145
|